Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year ...

If these drugs are designed to target cancer, why don't they work?Treatments that harness the power of the immune system to ...

New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow ...

Fred Hutch hematologist Marco Mielcarek, MD, PhD, has received a five-year, $3.5 million National Institutes of Health (NIH) U01 collaborative research grant to complete a clinical trial and related ...

Every time a muscle fiber forms, a single cell must perform one of the most dramatic architectural transformations in biology. A myoblast — a committed muscle precursor cell — has to abandon div ...

Novartis implemented halt after three cases of life-threatening immune reaction, cancer studies not affected Swiss drugmaker working with independent safety boards to review patient deaths Bristol ...

Explore the latest oncology biotech news, from clinical data to fundraising and biotech deals, in our September 2026 roundup.

Scientists are poking holes in established ideas about how cells live and die, and are harnessing these discoveries to fight diseases from cancer to autoimmune conditions.

Scientists want to create cells from scratch, to unveil life's origins or provide specialized functions. Are they close?

Residents of Ladera Ranch have tallied cancer cases and raised concerns about pesticides in parks and playing fields. Scientists say proving a cause is complicated.

Coverage of the new White House memorandum on combating cybercrime quickly reached the privateer label. CNN called the participants “cyber privateers,” ...